Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

CARE trial

One simple means of causing slow precipitation is to add denaturant to an aqueous solution of protein until the denaturant concentration is just below that required to precipitate the protein. Then water is allowed to evaporate slowly, which gently raises the concentration of both protein and denaturant until precipitation occurs. Whether the protein forms crystals or instead forms a useless amorphous solid depends on many properties of the solution, including protein concentration, temperature, pH, and ionic strength. Finding the exact conditions to produce good crystals of a specific protein often requires many careful trials and is perhaps more art than science. I will examine crystallization methods in Chapter 3. [Pg.10]

Type 2 diabetes careful trial is the only sure way of deciding who can be mainfained on oral therapy rather than on insulin. About 30% of patients will be adequately managed without oral therapy. When diet alone has failed to control Type 2 diabetes, it is necessary to add an oral agent the choice should fall first on... [Pg.691]

Influence of mixing of a plastic on the state of compaction in the asphalt mixture varied with sorts of plastics. Fig. 3 shows the relation air void percent of the compacted asphalt mixture with a quantity of each plastic and asphalt. The air void percent of compacted mixture decreased as the softening temperature of plastic mixed is higher. This suggests that careful trial mixing must be conducted to check the quality of the mixture, especially the air void, before construction. [Pg.37]

The ability of statins to lower hsCRP was first described for pravastatin using data accumulated in the Cholesterol and Recurrent Events (CARE) trial. These data were initially highly controversial because they suggested that statins have both hpid-lowering and antiinflammatory effects. However, confirmatory work rapidly showed the effect of statins on hsCRP to be a consistent and important class effect. Studies of atorvastatin, cerivastatin, lovastatin, pravastatin, and simvastatin have shown that, on average, median hsCRP concentrations decline 15% to 25% as early as 6 weeks after initiation of therapy. Importantly the magnitude of LDL cholesterol reduction caused by statin therapy is minimally correlated with the magnitude of hsCRP reduction. ... [Pg.965]

The Cholesterol and Recurrent Events (CARE) trial enrolled patients with a history of myocardial infarction and hypercholesterol-... [Pg.639]

Goldberg RB, Mellies MJ, Sacks EM, et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels Subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. Circulation 1998 98 2513-2519. [Pg.1367]

Darveau M, Notebaert E, Denault AY, et al. Recombinant human erythropoietin use in intensive care. Ann Pharmacother 2002 36 1068—1074. Hebert PC, Wells G, Martin C, et al. Do blood transfusions improve outcomes related to mechanical ventilation Chest 2001 119 1850—1857. Hebert PC, Wells G, Blajchman MA, et al, for the transfusion requirements in critical care investigators, Canadian critical care trials group. A multicenter, randonuzed, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999 340 409-417. [Pg.1830]

Markers of inflammation, especially CRP (measured with a highly sensitive technique, referred to as hs-CRP), have become the center of attention in recent years (22). This increased interest stems from several important observations made by Ridker and co-workers. Serum CRP has been shown to be an independent cardiovascular disease risk factor (23,24). High levels predict CAD death in healthy middle-aged men (25) and in patients with unstable CAD (26). In acute coronary syndromes, serum CRP concentrations correlate with the severity of endothelial dysfunction (27). In the CARE trial, subjects with elevated markers of inflammation (CRP and serum amyloid A > 90th percentile) were at high cardiovascular risk and responded best to pravastatin treatment in terms of cardiovascular risk reduction (28). The statin also reduced serum CRP concentrations (29). CRP co-incubated with LDL is readily taken up by macrophages, in contrast to native LDL, suggesting that CRP could promote foam cell formation (30). A link with endothelial dysfunction may be related to the fact that CRP decreases endothelial nitric oxide synthase (eNOS) expression and bioactivity in human aortic endothelial cells (31). [Pg.194]

Battersby M, et al. The development of selfmanagement for SA HealthPlus participants in the Australian coordinated care trials recollections of an evaluation. In C.D.o.H.a Aging, editor. Partners in health. Canberra Publications Production Unit, Public Affairs, Parliamentary and Access Branch ... [Pg.35]

Numerical Procedure. In the computer program one main loop was employed to solve the Reynolds equation In Its approximate form. Two convergency criteria were adopted, one for the maximum difference on any nodal pressure from the previous cycle and the other for a global difference check. Several thousand nodal points were adopted for each solution and careful trials established that a local criterion of 0.001 and a global one of 0.01 resulted In excellent accuracy whilst minimizing the computer run time. [Pg.454]

In many cases an optimized method may produce excellent results in the laboratory developing the method, but poor results in other laboratories. This is not surprising since a method is often optimized by a single analyst under an ideal set of conditions, in which the sources of reagents, equipment, and instrumentation remain the same for each trial. The procedure might also be influenced by environmental factors, such as the temperature or relative humidity in the laboratory, whose levels are not specified in the procedure and which may differ between laboratories. Finally, when optimizing a method the analyst usually takes particular care to perform the analysis in exactly the same way during every trial. [Pg.684]

Hypokalemia. Hypokalemia associated with thia2ide diuretic therapy has been knpHcated in the increased incidence of cardiac arrhythmias and sudden death (82). Several large clinical trials have been conducted in which the effects of antihypertensive dmg therapy on the incidence of cardiovascular complications were studied. The antihypertensive regimen included diuretic therapy as the first dmg in a stepped care (SC) approach to lowering the blood pressure of hypertensive patients. [Pg.212]

Conduct the trials as planned. Results should be carefully recorded in a table or machine along with any observations which may be regarded as potential errors... [Pg.309]

There are several valuable references to developing and applying a multicomponent distillation program, including Holland [26, 27,169], Prausnitz [52, 53], Wang and Henke [76], Thurston [167], Boston and Sullivan [6], Maddox and Erbar [115], and the pseudo-K method of Maddox and Fling [116]. Convergence of the iterative trials to reach a criterion requires careful evaluation [114]. There are sever-... [Pg.90]

Each item of plant and equipment is allocated a specific asset number. This number can be either for a complete boiler (with associated equipment) or a specific asset number for the boiler and individual asset numbers for the associated equipment. It is advisable to restrict this numbering sequence to a minimum while ensuring that it meets the specific needs of the company and location. Care must be exercised in determining the asset numbering during this manual phase if it is envisaged that, on completing a satisfactory trial period, the planned maintenance system will be transferred onto a computer. [Pg.785]

Samples of blood and excreta are taken for laboratory analysis. It is expected that, at the end of this phase, you will have a preliminary estimate of the maximum dose that may be safely tolerated in humans, and also a basic profile of the drug s pharmacokinetic behaviour. Depending on the availability of appropriate analytical indicators, pharmacodynamic and indicative efficacy data may also be generated. The data acquired must be carefully analysed and assessed so that, based on the findings, appropriate Phase II trials can be planned. [Pg.74]

The rights, safety, and well-being of the trial subjects should prevail over the interests of science or society Prior assessment should indicate that the anticipated benefits would outweigh any foreseeable risks or inconveniences The medical care given to, and medical decisions made on behalf of subjects should always be the responsibility of qualified medical personnel... [Pg.79]

O Connor PG, Carroll KM, Shi JM, et al Three methods of opioid detoxification in a primary care setting a randomized trial. Ann Intern Med 127 526-530, 1997 Oppenheimer E, Tobutt C, Taylor C, et al Death and survival in a cohort of heroin addicts from London clinics a 22-year follow-up study Addiction 89 1299—1308, 1994... [Pg.105]

Fleming MF, Barry KL, Manwell LB, et al Brief physician advice for problem alcohol drinkers a randomized controlled trial in community-based primary care practices. J Am Med Assoc 277 1029-1043, 1997 Goldstein MF, Deren S, Sung-Yeon K, et al Evaluation of an alternative program for MMTP drop-outs impact on treatment re-entry. Drug Alcohol Depend 66 181-187, 2002... [Pg.358]

Interim results from the SPRINT-1 phase 2 trial of boceprevir (SCH 503034) have been released. In subjects who received boceprevir plus interferon-a and ribavirin, viral RNA loads were suppressed at week 12 in between 70 and 79% of subjects infected with genotype 1 HCV, compared with only 34% in the interferon-o/ ribavirin standard of care arm (www.sch-plough.com/schering plough/news/release. jsp releaseID = 1064540). However, it is not yet known if this enhanced early response will translate into sustained response. [Pg.97]

Example 40 Trial calculations are done for Vanaiyt = (0.5) and Vprod = (0.9). .. (1.1) the required t-factors for p = 0.1 turn out to be 1.94. .. 1.66, which is equivalent to demanding n - 1. .. 120 calibration samples. Evidently, the case is critical and needs to be underpinned by experiments. Twenty or 30 calibration points might well be necessary if the calibration scheme is not carefully designed. [Pg.187]


See other pages where CARE trial is mentioned: [Pg.965]    [Pg.475]    [Pg.56]    [Pg.457]    [Pg.65]    [Pg.743]    [Pg.260]    [Pg.965]    [Pg.475]    [Pg.56]    [Pg.457]    [Pg.65]    [Pg.743]    [Pg.260]    [Pg.391]    [Pg.445]    [Pg.212]    [Pg.232]    [Pg.480]    [Pg.187]    [Pg.246]    [Pg.47]    [Pg.229]    [Pg.483]    [Pg.184]    [Pg.699]    [Pg.3]    [Pg.19]    [Pg.39]    [Pg.51]    [Pg.88]    [Pg.299]    [Pg.45]    [Pg.216]    [Pg.220]    [Pg.330]   


SEARCH



© 2024 chempedia.info